Fast‐acting insulin aspart in Japanese patients with type 1 diabetes: Faster onset, higher early exposure and greater early glucose‐lowering effect relative to insulin aspart

INTRODUCTION: Fast‐acting insulin aspart (faster aspart) is insulin aspart (IAsp) in a new formulation with two added excipients (niacinamide and L‐arginine) in order to obtain accelerated absorption after subcutaneous dosing. The present study compared the pharmacokinetic/pharmacodynamic characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiramoto, Masanari, Nishida, Tomoyuki, Hansen, Ann Kathrine, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835461/
https://www.ncbi.nlm.nih.gov/pubmed/28556616
http://dx.doi.org/10.1111/jdi.12697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835461/
https://www.ncbi.nlm.nih.gov/pubmed/28556616
http://dx.doi.org/10.1111/jdi.12697

Ejemplares similares